HIV Suicide Prevention With AI-DBT
Part of paid clinical trials in Newark, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT07339189
- Status
- Recruiting
Conditions
- AIDS (Acquired Immune Deficiency Syndrome)
- HIV
- Suicidal Ideation and Behavior
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- AI-DBT — BEHAVIORALParticipants will receive 14, 5 minute videos delivered 2x/week that describe DBT skills and tools. They will also receive the option of engaging in coaching sessions.
Study Details
One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.
Key Dates
- Start date
- Jan 7, 2026
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: usual careUsual care
- Experimental: AI-DBTAI-DBT group will receive 14 videos under 5 minutes across 7 weeks and the opportunity to engage in skills coaching with an AI chatbot
Primary Outcome Measure
Self-efficacy to manage emotions [ Time Frame: baseline, 6 and 12 weeks for long-form. ]
Central Contacts
- Jared Khan, MPH2016672414
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New Jersey Community Research Initiative | Newark | New Jersey | 07103 | - |
| RWJB Infectious Disease | Newark | New Jersey | 07112 | Jared Khan, MPH |
Find similar trials in Newark, NJ
Related Studies
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIVPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Birmingham, Alabama
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Washington D.C., District of Columbia
- Viral Load in Blood and Lymph Tissues in People Living With HIVRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland